Data_Sheet_1_A Multi-Sectoral Approach Improves Early Child Development in a Disadvantaged Community in Peru: Role of Community Gardens, Nutrition Workshops and Enhanced Caregiver-... by Doris González-Fernández (8613708)

“…</p><p>Objective: To compare improvement of health and development of children 0–3 years between intervention communities (IC) and control communities (CC) from peripheral settlements of Lima. …”

Proposed Model for Class II CCE. by Hiromitsu Tabeta (11237298)

“…<p>We previously reported a working model for Class II CCE [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009674#pgen.1009674.ref025" target="_blank">25</a>], showing that decreased cell numbers in cotyledons were exclusively attributed to decreased TAG-derived Suc, and that CCE might be mediated by IBA-derived IAA related mechanism. …”

Global aboveground and belowground Net Primary Productivity grids with 0.05° resolution from 1981 to 2018 using the Deep Learning model by Tao Zhou (9616574)

“…<p><a href="">Net primary productivity (NPP) in global ecosystems is a critical component of terrestrial carbon cycling and an essential indicator of ecosystem carbon sequestration capacity. …”

Data Sheet 1_Pre-sowing grain treatment with bio-AgNPs stimulates plant growth and affects redox homeostasis in maize.docx by Joanna Trzcińska-Wencel (21405185)

“…Introduction<p>In the pursuit of sustainable development, nanotechnology provides effective solutions for enhancing agricultural productivity. …”

DataSheet1_Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.pdf by Karolina Zebrowska (17444970)

“…For mNSCLC, inequalities decreased by 14.9 (−84.5; 19.0) months, or 12.2%, for the 5-group stratification; the IG decreased by 2.0 (−16.1; 5.1) months, or 5.5%. …”

Human mesenchymal stem/stromal cells (hMSCs) increased <i>Ccl2</i> expression and reduced inflammatory responses. by Kazumichi Yagura (4537504)

“…<p><b>(A)</b> All tested chemokine and receptor primers were detected at the expected rates in mouse samples (Ms). …”

Developmental phenotypes observed with knockdown of homologs of 3q29 genes in <i>X</i>. <i>laevis</i> models. by Mayanglambam Dhruba Singh (8447937)

“…<p>(<b>A</b>) To study brain morphology upon knockdown of <i>X</i>. …”

Presentation_1_NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder.zip by Anastasia Levchenko (9299687)

“…<p>GSK3B, BDNF, NGF, NRG1, HTR2C, and PIP4K2A play important roles in molecular mechanisms of psychiatric disorders. …”

Non Cardiogenic Pulmonary Edema Secondary to Acetazolamide: A rare adverse effect by Kusum Soni (22269871)

“…Her oxygen saturation and dyspnea improved rapidly, and lactate decreased to 1.9 mmol/L. She was discharged with stable vitals and complete symptom resolution.…”

Data_Sheet_1_Causal relationship between gut microbiota with subcutaneous and visceral adipose tissue: a bidirectional two-sample Mendelian Randomization study.ZIP by Feng Cao (38032)

“…Furthermore, Bacteroidetes (OR = 1.09, 95% CI: 1.01–1.17, p = 0.018), Eubacterium eligens group (OR = 1.09, 95% CI: 1.01–1.19, p = 0.037), Alloprevotella (OR = 1.05, 95% CI: 1.00–1.10, p = 0.038), and Phascolarctobacterium (OR = 1.07, 95% CI: 1.00–1.15, p = 0.042) were associated with VAT accumulation. …”

Data Sheet 1_Improved myocardial mitochondrial energy metabolism in rats with chronic heart failure by modifying fatty acid oxidation using an extract of sand-fired aconite (Jianch... by Hongtao Zhang (167639)

“…Additionally, it decreased MDA production (from 8.89 ± 0.36 nmol/mL to 5.11 ± 0.35 nmol/mL; P < 0.05) and increased SOD activity (from 264.82 ± 4.26 pg/mL to 529.64 ± 10.27 pg/mL; P < 0.001), Na⁺-K⁺-ATPase levels (from 7.19 ± 0.65 μmol/mL to 14.08 ± 0.28 μmol/mL; P < 0.001), Ca²⁺-Mg²⁺-ATPase levels (from 0.86 ± 0.03 μmol/mL to 1.40 ± 0.02 μmol/mL; P < 0.05), CD36 levels (P < 0.05), and CPT1 levels (P < 0.01). …”

Image1_Characterizing the interindividual postexercise hypotension response for two order groups of concurrent training in patients with morbid obesity.jpg by Cristian Álvarez (5055473)

“…RT + ET) on the blood pressure responses; 2) characterize these responses in responders and nonresponders, and 3) identify potential baseline outcomes for predicting blood pressure decreases as responders.</p><p>Methods: A quasi-experimental study developed in sedentary morbidly obese men and women (age 43.6 ± 11.3 years; body mass index [BMI] ≥40 kg/m²) was assigned to a CT group of ET plus RT (ET + RT; n = 19; BMI 47.8 ± 16.7) or RT plus ET order group (RT + ET; n = 17; BMI 43.0 ± 8.0). …”

Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Table3_Effects of three modes of physical activity on physical fitness and hematological parameters in older people with sarcopenic obesity: A systematic review and meta-analysis.D... by Min Zhuang (218356)

“…Compared with a no-PA control group, AT decreased BW (SMD = −0.64, 95% CI: −1.13 to −0.16, p = 0.009, I² = 0%) and BMI (SMD = −0.69, 95% CI: −1.18 to −0.21, p = 0.005, I² = 0%); RT improved BF% (SMD = −0.43, 95% CI: −0.63 to −0.22, p < 0.0001, I² = 38%), ASMI (SMD = 0.72, 95% CI: 0.24 to 1.21, p = 0.004, I² = 0%), ASM (SMD = −0.94, 95% CI: −1.46 to −0.42, p = 0.0004), HG (SMD = 1.06, 95% CI: 0.22 to 1.91, p = 0.01, I² = 90%) and KES (SMD = 1.06, 95% CI: 0.73 to 1.39, p < 0.00001, I² = 14%); MT improved BMI (SMD = −0.77, 95% CI: −1.26 to −0.28, p = 0.002, I² = 0%), BF% (SMD = −0.54, 95% CI: −0.83 to −0.25, p = 0.0003, I² = 0%), ASMI (SMD = 0.70, 95% CI: 0.22 to 1.19, p = 0.005, I² = 0%) and GS (SMD = 0.71, 95% CI: 0.23 to 1.18, p = 0.004, I² = 37%). …”

Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”

Table2_Effects of three modes of physical activity on physical fitness and hematological parameters in older people with sarcopenic obesity: A systematic review and meta-analysis.D... by Min Zhuang (218356)

“…Compared with a no-PA control group, AT decreased BW (SMD = −0.64, 95% CI: −1.13 to −0.16, p = 0.009, I² = 0%) and BMI (SMD = −0.69, 95% CI: −1.18 to −0.21, p = 0.005, I² = 0%); RT improved BF% (SMD = −0.43, 95% CI: −0.63 to −0.22, p < 0.0001, I² = 38%), ASMI (SMD = 0.72, 95% CI: 0.24 to 1.21, p = 0.004, I² = 0%), ASM (SMD = −0.94, 95% CI: −1.46 to −0.42, p = 0.0004), HG (SMD = 1.06, 95% CI: 0.22 to 1.91, p = 0.01, I² = 90%) and KES (SMD = 1.06, 95% CI: 0.73 to 1.39, p < 0.00001, I² = 14%); MT improved BMI (SMD = −0.77, 95% CI: −1.26 to −0.28, p = 0.002, I² = 0%), BF% (SMD = −0.54, 95% CI: −0.83 to −0.25, p = 0.0003, I² = 0%), ASMI (SMD = 0.70, 95% CI: 0.22 to 1.19, p = 0.005, I² = 0%) and GS (SMD = 0.71, 95% CI: 0.23 to 1.18, p = 0.004, I² = 37%). …”

Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Liver stiffness by TE decreased in the SGLT2i group (−4.0 ± 1.1 kPa), while it increased in the insulin group (+3.0 ± 2.5 kPa; p < 0.01). …”